Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema.

چکیده

To assess the anatomic and functional outcomes in eyes with diabetic macular edema (DME) switched from intravitreal aflibercept to faricimab in a real-world setting. Retrospective, interventional consecutive case series. Patients with DME were switched from aflibercept to faricimab and categorized…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط